Aimmune Therapeutics, Inc.

RHUMBLINE ADVISERS

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/12/2020

Shares

67,157

Value ($000)

2,314

Weight

0.0%

2019 Q4 - 2020 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/12/2020	2,314	0.0%	67,157	9/30/2020
2020 Q2	8/13/2020	1,493	0.0%	89,327	6/30/2020
2020 Q1	5/6/2020	1,120	0.0%	77,674	3/31/2020
2019 Q4	2/5/2020	2,304	0.0%	68,831	12/31/2019